# Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults

> **NCT00968539** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 130 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK investigational vaccine GSK2340272A
- **BIOLOGICAL:** GSK investigational vaccine GSK2340269A

## Key facts

- **NCT ID:** NCT00968539
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09-08
- **Primary completion:** 2010-09-28
- **Final completion:** 2010-09-28
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00968539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00968539, "Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT00968539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*